Cost-effectiveness of a mobile technology-enabled primary care intervention for cardiovascular disease risk management in rural Indonesia.


Journal

Health policy and planning
ISSN: 1460-2237
Titre abrégé: Health Policy Plan
Pays: England
ID NLM: 8610614

Informations de publication

Date de publication:
17 May 2021
Historique:
accepted: 12 02 2021
pubmed: 14 3 2021
medline: 29 7 2021
entrez: 13 3 2021
Statut: ppublish

Résumé

Cardiovascular diseases (CVD) are the leading cause of death in Indonesia, and there are large disparities in access to recommended preventative treatments across the country, particularly in rural areas. Technology-enabled screening and management led by community health workers have been shown to be effective in better managing those at high risk of CVD in a rural Indonesian population; however, the economic impacts of implementing such an intervention are unknown. We conducted a modelled cost-effectiveness analysis of the SMARThealth intervention in rural villages of Malang district, Indonesia from the payer perspective over a 10-year period. A Markov model was designed and populated with epidemiological and cost data collected in a recent quasi-randomized trial, with nine health states representing a differing risk for experiencing a major CVD event. Disability-Adjusted Life Years (DALYs) were estimated for the intervention and usual care using disability weights from the literature for major CVD events. Annual treatment costs for CVD treatment and prevention were $US83 under current care and $US144 for those receiving the intervention. The intervention had an incremental cost-effectiveness ratio of $4288 per DALY averted and $3681 per major CVD event avoided relative to usual care. One-way and probabilistic sensitivity analyses demonstrated that the results were robust to plausible variations in model parameters and that the intervention is highly likely to be considered cost-effective by decision-makers across a range of potentially acceptable willingness to pay levels. Relative to current care, the intervention was a cost-effective means to improve the management of CVD in this rural Indonesian population. Further scale-up of the intervention offers the prospect of significant gains in population health and sustainable progress toward universal health coverage for the Indonesian population.

Identifiants

pubmed: 33712844
pii: 6169376
doi: 10.1093/heapol/czab025
doi:

Types de publication

Journal Article

Langues

eng

Pagination

435-443

Informations de copyright

© The Author(s) 2021. Published by Oxford University Press in association with The London School of Hygiene and Tropical Medicine. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Auteurs

Blake Angell (B)

The George Institute for Global Health, University of New South Wales, Level 5 1 King Street Newtown, Sydney, Australia.
UCL Institute for Global Health, UCL (University College London), 30 Guilford Street, London, WC1N 1EH, UK.

Thomas Lung (T)

The George Institute for Global Health, University of New South Wales, Level 5 1 King Street Newtown, Sydney, Australia.
Faculty of Medicine and Health, School of Public Health, Edward Ford Building A27, University of Sydney, Sydney, NSW 2006, Australia.

Devarsetty Praveen (D)

Primary health care research, George Institute for Global Health, 308-309, Third Floor, Elegance Tower Plot No. 8, Jasola District Centre, New Delhi 110025, India.
Faculty of Medicine, University of New South Wales, Sydney NSW 2052, Australia.
Prasanna School of Public Health, Manipal Academy of Higher Education, Madhav Nagar, Eshwar Nagar, Manipal, Karnataka - 576104, India.

Asri Maharani (A)

Division of Nursing, Midwifery and Social Work University of Manchester, Oxford Road, Manchester, M13 9PL Lancashire, UK.

Sujarwoto Sujarwoto (S)

Department of Public Administration, University of Brawijaya, Jl MT Haryono 163 Malang, Jawa Timur, 65145, Indonesia.

Anna Palagyi (A)

The George Institute for Global Health, University of New South Wales, Level 5 1 King Street Newtown, Sydney, Australia.

Delvac Oceandy (D)

Division of Cardiovascular Sciences, The University of Manchester, Manchester Academic Health Science Centre, Oxford Road, Manchester M13 9PT, UK.
Department of Biomedical Sciences, Faculty of Medicine, Universitas Airlangga, Jl. Prof Dr Moestopo 47, Surabaya 60132, Indonesia.

Gindo Tampubolon (G)

Global Development Institute, The University of Manchester, Arthur Lewis Building 2.025 Oxford Road, Manchester M13 9PL, UK.

Anushka Patel (A)

The George Institute for Global Health, University of New South Wales, Level 5 1 King Street Newtown, Sydney, Australia.

Stephen Jan (S)

The George Institute for Global Health, University of New South Wales, Level 5 1 King Street Newtown, Sydney, Australia.
Faculty of Medicine and Health, School of Public Health, Edward Ford Building A27, University of Sydney, Sydney, NSW 2006, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH